American Well Price to Book Ratio 2019-2025 | AMWL
Historical price to book ratio values for American Well (AMWL) over the last 10 years. The current price to book ratio for American Well as of January 22, 2026 is 0.28.
| American Well Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-22 | 4.93 | 0.30 | |
| 2025-09-30 | 6.15 | $16.38 | 0.38 |
| 2025-06-30 | 8.89 | $18.31 | 0.49 |
| 2025-03-31 | 7.88 | $19.37 | 0.41 |
| 2024-12-31 | 7.25 | $20.31 | 0.36 |
| 2024-09-30 | 9.48 | $24.27 | 0.39 |
| 2024-06-30 | 6.50 | $25.27 | 0.26 |
| 2024-03-31 | 16.22 | $28.60 | 0.57 |
| 2023-12-31 | 29.80 | $33.29 | 0.90 |
| 2023-09-30 | 23.40 | $36.22 | 0.65 |
| 2023-06-30 | 42.00 | $45.33 | 0.93 |
| 2023-03-31 | 47.20 | $50.89 | 0.93 |
| 2022-12-31 | 56.60 | $78.22 | 0.72 |
| 2022-09-30 | 71.80 | $80.28 | 0.89 |
| 2022-06-30 | 86.40 | $84.94 | 1.02 |
| 2022-03-31 | 84.20 | $90.99 | 0.93 |
| 2021-12-31 | 120.80 | $96.30 | 1.25 |
| 2021-09-30 | 182.20 | $100.06 | 1.82 |
| 2021-06-30 | 251.60 | $98.52 | 2.55 |
| 2021-03-31 | 347.40 | $101.48 | 3.42 |
| 2020-12-31 | 506.60 | $105.79 | 4.79 |
| 2020-09-30 | 592.80 | $110.72 | 5.35 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.074B | $0.254B |
| American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.120B | 41.77 |
| Tempus AI (TEM) | United States | $11.621B | 0.00 |
| Doximity (DOCS) | United States | $7.503B | 30.89 |
| Hims & Hers Health (HIMS) | United States | $6.577B | 53.50 |
| IRhythm Holdings (IRTC) | United States | $5.273B | 0.00 |
| Hinge Health (HNGE) | United States | $3.268B | 0.00 |
| Privia Health (PRVA) | United States | $2.903B | 181.54 |
| 10x Genomics (TXG) | United States | $2.870B | 0.00 |
| Heartflow (HTFL) | United States | $2.857B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.795B | 46.25 |
| Omnicell (OMCL) | United States | $2.265B | 46.31 |
| Azenta (AZTA) | United States | $1.857B | 76.17 |
| Enovis (ENOV) | United States | $1.354B | 7.11 |
| Clover Health Investments (CLOV) | United States | $1.354B | 0.00 |
| Schrodinger (SDGR) | United States | $1.210B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.117B | 0.00 |
| Phreesia (PHR) | United States | $0.942B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.861B | 0.00 |
| Talkspace (TALK) | United States | $0.633B | 127.33 |
| Standard BioTools (LAB) | United States | $0.631B | 0.00 |
| Claritev (CTEV) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.424B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.366B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.303B | 13.90 |
| Senseonics Holdings (SENS) | United States | $0.295B | 0.00 |
| CapsoVision (CV) | United States | $0.289B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.264B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.183B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| CareCloud (CCLD) | United States | $0.124B | 6.81 |
| Outset Medical (OM) | United States | $0.094B | 0.00 |
| Pulmonx (LUNG) | United States | $0.077B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.062B | 0.00 |
| 111 (YI) | China | $0.046B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.035B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.019B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.012B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |